Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
95.86
+3.48 (3.77%)
Sep 14, 2026, 1:21 PM EDT - Market open
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $6.35 billion as of September 14, 2026. Its market cap has increased by 1,000.47% in one year.
Market Cap
6.35B
Enterprise Value
5.22B
1-Year Change
1,000.47%
Ranking
Category
Stock Price
$95.86
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $6.35B, an increase of 647.28%. That is a compound annual growth rate of 167.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 6.35B | 332.56% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 6.88B |
| Scholar Rock Holding | 6.75B |
| CG Oncology | 6.41B |
| Mirum Pharmaceuticals | 6.38B |
| Travere Therapeutics | 6.24B |
| Dianthus Therapeutics | 5.94B |
| Cogent Biosciences | 5.80B |
| Xenon Pharmaceuticals | 5.68B |